Gerard J Michel, an insider of Aastrom Biosciences, recently cashed-in 15,000 options. The options were exercised at $1.95, while the disposals took place at $12.65 per share, on October 15, 2018. Michel continues to hold 150,960 shares of the company. Michel operates out of Cambridge, MA. Some additional info was provided as follows:
The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2018.
These options, representing the right to purchase a total of 80,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 9, 2016, which was one quarter after the date on which the option was
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Aastrom Biosciences makes a similar move, sign up!
Other recent filings from the company include the following:
Aastrom: Vericel Announces Submission Of Biologics License Application To The Fda For Nexobrid For The Treatment Of Severe Thermal Burns - June 30, 2020
Aastrom Biosciences insider just cashed-in 14,751 options - June 24, 2020
Aastrom Biosciences insider just disposed of 1,112 shares - June 18, 2020
Brown Capital Management, LLC just provided an update on share ownership of Aastrom Biosciences - June 10, 2020